IMMUNE-RELATED PNEUMONIA

Clinical trials for IMMUNE-RELATED PNEUMONIA explained in plain language.

Never miss a new study

Get alerted when new IMMUNE-RELATED PNEUMONIA trials appear

Sign up with your email to follow new studies for IMMUNE-RELATED PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for patients with Radiation-Damaged lungs

Disease control Not yet recruiting

This study is testing whether a drug called pirfenidone can help people who develop lung injury after radiation therapy for cancer, sometimes combined with immunotherapy. About 298 adults with mild to moderate lung damage will take either pirfenidone or a placebo (inactive pill) …

Matched conditions: IMMUNE-RELATED PNEUMONIA

Phase: PHASE2, PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

IMMUNE-RELATED PNEUMONIA

Get alerted when new IMMUNE-RELATED PNEUMONIA trials appear

New hope for patients with Radiation-Damaged lungs